Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Evaluate published an article under the heading "Sabinsa Takes Legal Action Against Curcumin Adulteration" dated 1 June 2015 on its website www.evaluategroup.com.
The article was subsequently removed on the direction of the Bangalore Court in case number: O.S. No.4898/2015. This article alleged that Bayir Extracts Private Limited had been referred to the police by the Magistrate Court in Bangalore and would be investigated for adulterating its curcumin products with synthetic material. In fact we have since been informed by Bayir Extracts that it had not been referred to the police, and there had been no order for an investigation into its products by that date.
We wish to apologise to Bayir Extracts for the publication of this inaccurate information, which was part of an automated citation of publicly available information at that time.
Evaluate is the trusted provider of commercial intelligence including product sales and consensus forecasts to 2022 for commercial teams and their advisors within the global life science industry.
We help our clients make high value decisions through superior quality, timely, must-have data and insights, combined with personalised, expert client support.
Our online subscription services cover the pharmaceutical, biotech and medtech sectors. Our Custom Services group delivers project based analytical and data services.
Vantage – our independent and award-winning editorial team – offers data-driven, forward-looking news, commentary and analysis on a daily basis.